StartsideZEG • ETR
add
AstraZeneca
Forrige sluttkurs
128,30 €
Dagsintervall
127,60 € - 128,60 €
Årsintervall
112,35 € - 158,20 €
Markedsverdi
207,00 mrd. USD
Gjennomsnittlig volum
26,43k
P/E-tall
-
Utbytte
-
Hovedbørs
LON
I nyhetene
Økonomi
Resultatregnskap
Omsetning
Nettoomsetning
(USD) | sep. 2024info | Endring år til år |
---|---|---|
Omsetning | 13,56 mrd. | 18,04 % |
Driftskostnader | 7,79 mrd. | 4,64 % |
Nettoomsetning | 1,43 mrd. | 4,00 % |
Netto resultatmargin | 10,53 | −11,96 % |
Fortjeneste per aksje | 2,08 | 140,46 % |
EBITDA | 4,63 mrd. | 45,69 % |
Faktisk avgiftssats | 21,61 % | — |
Balanseregnskap
Totale aktiva
Totale passiva
(USD) | sep. 2024info | Endring år til år |
---|---|---|
Kontant / kortsiktige inv. | 4,93 mrd. | −3,62 % |
Totale aktiva | 104,92 mrd. | 9,20 % |
Totale passiva | 64,12 mrd. | 8,92 % |
Total egenkapital | 40,80 mrd. | — |
Utestående aksjer | 1,55 mrd. | — |
P/B-forhold | 4,88 | — |
Avkastning på aktiva | 7,92 % | — |
Avkastning på kapital | 11,38 % | — |
Kontantstrøm
Netto kontantstrøm
(USD) | sep. 2024info | Endring år til år |
---|---|---|
Nettoomsetning | 1,43 mrd. | 4,00 % |
Kontantstrøm fra drift | 3,38 mrd. | 8,64 % |
Kontanter fra investering | −1,51 mrd. | −24,00 % |
Kontanter fra finansiering | −4,13 mrd. | −51,54 % |
Netto kontantstrøm | −2,24 mrd. | −163,15 % |
Fri kontantstrøm | 2,05 mrd. | −12,38 % |
Om
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, United Kingdom. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, United Kingdom; Gothenburg, Sweden and Gaithersburg in Maryland, U.S.
AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje. Throughout the twentieth century, it grew into the largest pharmaceutical company in Sweden. Wikipedia
Administrerende direktør
Grunnlagt
6. apr. 1999
Hovedkvarter
Nettsted
Ansatte
89 900